AK Medical's (HKG:1789) attributable profit rose 50% to 273.9 million yuan in 2024 from 182.1 million yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.
Earnings per share at the orthopedic products company increased to 0.24 yuan from 0.16 yuan in the previous year.
Revenue grew 23% to 1.35 billion yuan from 1.09 billion yuan a year earlier.
The company declared a final dividend of HK$0.072 per share, payable July 18 to shareholders on record as of June 18.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.